Rivastigmine
Encyclopedia : R : RI : RIV : Rivastigmine
Rivastigmine tartrate (Exelon) is a medication developed and marketed by Novartis for the treatment of Alzheimer's disease and Dementia with Lewy bodies. The drug inhibits cholinesterase and butyrylcholinesterase and is designed for symptomatic treatment of early- to middle-stage Alzheimer's.
See also
- "Acetylcholinesterase inhibitors" section of the "Alzheimer's disease" article
| Anticholinesterases (N06DA, N07AA) [http://encycl.opentopia.com/ edit]
|
| Metrifonate - Physostigmine - Neostigmine - Pyridostigmine - Ambenonium - Demarcarium - Rivastigmine - Galantamine - Donepezil - Tacrine - Edrophonium |
From Wikipedia, the Free Encyclopedia. Original article here. Support Wikipedia by contributing or donating.
All text is available under the terms of the GNU Free Documentation License See Wikipedia Copyrights for details.